title: Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors: Aurélie
authors: A
authors: Jaspers
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.|Giga-Research, University of Liège, Liège, Belgium.
authors: Frédéric
authors: F
authors: Baron
authors: Clinical Hematology, Acute Leukemia & Stem Cell Transplantation Unit, , University Hospital Gasthuisberg, Leuven, Belgium.
authors: Johan
authors: J
authors: Maertens
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.|Division of Hematology, Department of Medicine, CHR La Citadelle, Liège, Belgium.
authors: Bernard
authors: B
authors: De Prijck
authors: Department of Clinical Hematology and Stem Cell Laboratory, Universitair Ziekenhuis Brussel, Belgium.
authors: Rik
authors: R
authors: Schots
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors: Christophe
authors: C
authors: Bonnet
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors: Kaoutar
authors: K
authors: Hafraoui
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors: Évelyne
authors: É
authors: Willems
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.|Giga-Research, University of Liège, Liège, Belgium.
authors: Sophie
authors: S
authors: Servais
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors: Georges
authors: G
authors: Fillet
authors: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.|Giga-Research, University of Liège, Liège, Belgium.
authors: Yves
authors: Y
authors: Beguin
mesh_terms: D000740:Anemia / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000068256:Darbepoetin alfa; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005290:Ferric Compounds / Q000627:therapeutic use*; D000077605:Ferric Oxide, Saccharated; D005500:Follow-Up Studies; D005937:Glucaric Acid; D006397:Hematinics / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007275:Injections, Intravenous; D013395:Sucrose / Q000627:therapeutic use*; D016019:Survival Analysis; D014182:Transplantation, Autologous
chemical_list: D005290:Ferric Compounds; D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D013395:Sucrose; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid